← Open Payments lookup

CHARLES COLE: Open Payments

NPI 1316021751 · MEADVILLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$896 in 44 payments from 16 companies in 2025. Trend: 2023 $878 · 2024 $797 · 2025 $896

Food & beverage: $896
CompanyPaymentsAmount
ABBVIE INC.8$240
Otsuka America Pharmaceutical, Inc.5$102
Novartis Pharmaceuticals Corporation3$69
Amgen Inc.3$62
Lundbeck LLC3$61
Lilly USA, LLC3$59
Takeda Pharmaceuticals U.S.A., Inc.3$50
PFIZER INC.3$46
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$42
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$40

Products named: REXULTI, LUMIGAN, VRAYLAR, OTEZLA, MOUNJARO, TRINTELLIX, CAPLYTA, XIFAXAN.

Industry payments across PA — which companies pay providers there.